Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and safety of efalizumab in
treating hydradenitis suppurativa, and to evaluate the duration of the benefit seen in people
who respond to treatment with efalizumab, after the medication is stopped.
Phase:
Phase 1
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health